Cg Oncology Inc (CGON) last year’s performance of -3.56% is a clear signal for an entertaining trading season.

Sana Meer

On Monday, Cg Oncology Inc (NASDAQ: CGON) opened lower -4.19% from the last session, before settling in for the closing price of $41.79. Price fluctuations for CGON have ranged from $14.80 to $46.01 over the past 52 weeks.

Company’s average yearly earnings per share was noted -54.47% at the time writing. With a float of $50.68 million, this company’s outstanding shares have now reached $78.28 million.

Cg Oncology Inc (CGON) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cg Oncology Inc is 37.18%, while institutional ownership is 77.50%. The most recent insider transaction that took place on Nov 17 ’25, was worth 41,430. In this transaction Director of this company sold 1,000 shares at a rate of $41.43, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 13 ’25, when Company’s Director sold 1,000 for $43.25, making the entire transaction worth $43,250. This insider now owns 0 shares in total.

Cg Oncology Inc (CGON) Recent Fiscal highlights

If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.48 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.46) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.

Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators

Check out the current performance indicators for Cg Oncology Inc (CGON). In the past quarter, the stock posted a quick ratio of 22.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1488.42.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.98, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -2.60 in one year’s time.

Technical Analysis of Cg Oncology Inc (CGON)

Compared to the last year’s volume of 1.09 million, its volume of 0.88 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 73.66%.

During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 71.79%, which indicates a significant increase from 54.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.59 in the past 14 days, which was lower than the 1.98 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $41.32, while its 200-day Moving Average is $31.50. Nevertheless, the first resistance level for the watch stands at $42.02 in the near term. At $44.00, the stock is likely to face the second major resistance level. The third major resistance level sits at $45.44. If the price goes on to break the first support level at $38.60, it is likely to go to the next support level at $37.16. Now, if the price goes above the second support level, the third support stands at $35.18.

Cg Oncology Inc (NASDAQ: CGON) Key Stats

There are currently 80,666K shares outstanding in the company with a market cap of 3.23 billion. Presently, the company’s annual sales total 1,140 K according to its annual income of -88,040 K. Last quarter, the company’s sales amounted to 1,670 K and its income totaled -43,810 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.